Skip to content

Transanal and transperineal total prostatectomy with total mesorectal excision for lower rectal cancer and proctal cancer

Transanal and transperineal total prostatectomy with total mesorectal excision for lower rectal cancer and proctal cancer - Transanal and transperineal total prostatectomy with total mesorectal excision

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029229
Enrollment
5
Registered
2017-09-22
Start date
2017-09-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Rectal Cancer

Interventions

Transanal and transperineal total prostatectomy with total mesorectal excision

Sponsors

Saku Central Hospital Advanced Care Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The patients with the lower rectal cancer which invades the only middle part of the seminal vesicles or the prostate. 2) The patients who agreed the entry of this study of their own free will in writing by a principal or a substitute after they had comprehended it well by enough explanation.

Exclusion criteria

Exclusion criteria: 1) The patients with the lower rectal cancer which had widespread invasion of the seminal vesicles, the prostate, the pelvic nerve, the urinary bladder, and the urethra are excluded. 2) The patients who underwent neoadjuvant CRT in particular more than 45 Gry are e excluded because of much risk of leakage of the anastomotic site between the urinary bladder and the urethra. 3) When the proper surgical field or further improvement in manipulation cannot be obtained during TaTMEP or TpTMEP, the approach method should be changed into other approaches such as laparoscopy or open laparotomy, or other surgical methods such as transanal or transperineal total pelvic exenteration. 4) The patients who are inappropriate as the subjects of this study by the corresponding doctor are excluded.

Design outcomes

Primary

MeasureTime frame
Surgical bleeding, surgical time, circumferential resected margin of the surgical specimen, leakage at the anastomotic site between the bladder and the urethra, post-surgical urinary function regarding voiding and continence

Secondary

MeasureTime frame
Post-surgical complications including urinary tract infection, pelvic abscess, paresis of intestine, and leakage at the coloanal anastomotic site post sphincter preserving surgery, closure rate of covering ileostoma, 3-year local recurrence rate, 3-year overall survival rate, and 3-year disease-free survival.

Countries

Japan

Contacts

Public ContactMiyuki Niimi

Saku Central Hospital Advanced Care Center Clinical Research Center

ctroffice@sakuhp.or.jp0267-62-8181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026